Assembly Biosciences (ASMB) Profit After Tax (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Profit After Tax of -$9.1 million for Q1 2026, down 2.47% year-over-year from -$9.3 million in Q1 2025, and down 141.1% quarter-over-quarter from $22.1 million in Q4 2025.
Assembly Biosciences (ASMB) Profit After Tax (2010 - 2026) Analysis & Trends
Assembly Biosciences' Profit After Tax history runs 17 years deep, the most recent figure standing at -$9.1 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 2.47% year-over-year to -$9.1 million; the TTM figure through Mar 2026 stood at -$6.4 million (up 84.02% YoY), while the FY2025 annual figure was -$6.1 million, up 84.81% from the prior year.
- Profit After Tax for Q1 2026 stood at -$9.1 million, down from $22.1 million in the prior quarter.
- The five-year high for Profit After Tax was $22.1 million in Q4 2025, with the low at -$24.5 million in Q2 2022.
- The 5-year median for Profit After Tax is -$10.8 million (2023), against an average of -$12.3 million.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax declined 22.99% in 2022, then jumped 312.61% in 2025.
- Assembly Biosciences' Profit After Tax stood at -$22.2 million in 2022, then soared by 51.49% to -$10.8 million in 2023, then gained by 3.51% to -$10.4 million in 2024, then surged by 312.61% to $22.1 million in 2025, then sank by 141.1% to -$9.1 million in 2026.
- Business Quant data shows ASMB's Profit After Tax at -$9.1 million in Q1 2026, $22.1 million in Q4 2025, and -$9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | -4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.11 Mn |
| Mar 31, 2026 | -9.08 Mn |
| Dec 31, 2025 | 22.09 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -8.86 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -9.48 Mn |
| Jun 30, 2024 | -11.21 Mn |
| Mar 31, 2024 | -9.08 Mn |
| Dec 31, 2023 | -10.77 Mn |
| Sep 30, 2023 | -14.42 Mn |
| Jun 30, 2023 | -16.90 Mn |
| Mar 31, 2023 | -18.95 Mn |
| Dec 31, 2022 | -22.20 Mn |
| Sep 30, 2022 | -23.15 Mn |
| Jun 30, 2022 | -24.46 Mn |
| Mar 31, 2022 | -23.09 Mn |
| Dec 31, 2021 | -60.26 Mn |
| Sep 30, 2021 | -18.82 Mn |